- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有81家主力机构披露2025-12-31报告期持股数据，持仓量总计2382.31万股，占流通A股5.54%
- 波段诊断：
-
技术面诊股
诊断结果：5.1技术面打败了21%的股票
技术面评分前10的股票
近期的平均成本为17.75元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为17.75元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"17.75","date":1776327274,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2026.04.17","stock":"-0.73","trade":null,"ind":"0.60"},{"date":"2026.04.16","stock":"0.73","trade":null,"ind":"2.05"},{"date":"2026.04.15","stock":"0.11","trade":null,"ind":"-0.97"},{"date":"2026.04.14","stock":"0.06","trade":null,"ind":"1.61"},{"date":"2026.04.13","stock":"-1.17","trade":null,"ind":"0.69"},{"date":"2026.04.10","stock":"0.79","trade":null,"ind":"2.24"},{"date":"2026.04.09","stock":"-2.36","trade":null,"ind":"-0.33"},{"date":"2026.04.08","stock":"3.11","trade":null,"ind":"4.79"},{"date":"2026.04.07","stock":"-0.56","trade":null,"ind":"0.36"},{"date":"2026.04.03","stock":"-4.71","trade":null,"ind":"-0.99"},{"date":"2026.04.02","stock":"-0.27","trade":null,"ind":"-1.60"},{"date":"2026.04.01","stock":"2.13","trade":null,"ind":"1.70"},{"date":"2026.03.31","stock":"-0.76","trade":null,"ind":"-1.81"},{"date":"2026.03.30","stock":"-0.54","trade":null,"ind":"-0.25"},{"date":"2026.03.27","stock":"1.81","trade":null,"ind":"1.13"},{"date":"2026.03.26","stock":"-2.56","trade":null,"ind":"-1.41"},{"date":"2026.03.25","stock":"0.43","trade":null,"ind":"1.95"},{"date":"2026.03.24","stock":"1.47","trade":null,"ind":"1.43"},{"date":"2026.03.23","stock":"-6.89","trade":null,"ind":"-3.76"},{"date":"2026.03.20","stock":"-1.74","trade":null,"ind":"-0.25"},{"date":"2026.03.19","stock":"2.19","trade":null,"ind":"-2.02"}]
万孚生物,深证成指,医疗器械指数
压力支撑
该股压力位为17.75元，支撑位为17.63元。
[{"text":"\u538b\u529b\u4f4d","value":"17.75","date":1776355200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"17.63","date":1776355200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.7资金面打败了1%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月17日 20:30
| 机构今日流向(万元) | -1427.16 | 机构5日流向(万元) | -4006.48 |
| 机构10日流向(万元) | -5467.26 | 机构20日流向(万元) | -7418.61 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少7453.5万股，其中基金净减仓12家，主力净减仓33家，请投资者中长期谨慎为宜。
截止2025-12-31，共81家主力机构（基金81家），持仓量总计2382.31万股，占流通A股5.54%
其中，基金持仓与2025-06-30相比：
增仓：20家 ，增持 129.76万股
减仓：32家 ，减持 257.64万股
新出现在主力名单中：27家 ，持有291.8万股
从主力名单中消失：60家 ，原持有7617.42万股
其中，基金持仓与2025-06-30相比：
增仓：20家 ，增持 129.76万股
减仓：32家 ，减持 257.64万股
新出现在主力名单中：27家 ，持有291.8万股
从主力名单中消失：60家 ，原持有7617.42万股
消息面诊股
诊断结果：4.4消息面打败了8%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 万孚生物：4月16日获融资买入830.64万元
2026-04-17 - 几亿元的利润说调就调！29家公司业绩预告“大变脸”
2026-04-16 - 万孚生物：4月15日获融资买入619.73万元
2026-04-16 - 万孚生物：4月14日获融资买入1401.01万元
2026-04-15 - 万孚生物：4月13日获融资买入666.31万元
2026-04-14 - 医药行业派2025年成绩单 盈利标尺下的“冰火两重
2026-04-14 - 年报季业绩预告“变脸”频发 多家公司收监管函
2026-04-14 - 万孚生物：4月10日获融资买入617.89万元
2026-04-13 - 万孚生物：4月9日获融资买入1367.77万元
2026-04-10 - 万孚生物连续2日融资买入额增长率超50%，多头加速
2026-04-10
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2026-02-13 |
| 一般消息 | 募资投向 | 2026-02-12 | |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-30 |
| 一般消息 | 高管变动 | 因个人工作原因 | 2026-01-23 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-01-09 |
| 一般消息 | 高管变动 | 因公司内部治理结构调整 | 2025-12-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-11 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-08-20 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-20 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-20 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-05-09 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 2条 | 1条 | 1条 |
行业面诊股
诊断结果：0.0行业面打败了2%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.04.17","price":"0.60","value":null},{"date":"2026.04.16","price":"2.05","value":null},{"date":"2026.04.15","price":"-0.97","value":null},{"date":"2026.04.14","price":"1.61","value":null},{"date":"2026.04.13","price":"0.69","value":null},{"date":"2026.04.10","price":"2.24","value":null},{"date":"2026.04.09","price":"-0.33","value":null},{"date":"2026.04.08","price":"4.79","value":null},{"date":"2026.04.07","price":"0.36","value":null},{"date":"2026.04.03","price":"-0.99","value":null},{"date":"2026.04.02","price":"-1.60","value":null},{"date":"2026.04.01","price":"1.70","value":null},{"date":"2026.03.31","price":"-1.81","value":null},{"date":"2026.03.30","price":"-0.25","value":null},{"date":"2026.03.27","price":"1.13","value":null},{"date":"2026.03.26","price":"-1.41","value":null},{"date":"2026.03.25","price":"1.95","value":null},{"date":"2026.03.24","price":"1.43","value":null},{"date":"2026.03.23","price":"-3.76","value":null},{"date":"2026.03.20","price":"-0.25","value":null},{"date":"2026.03.19","price":"-2.02","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 海泰新光 | 111.01% | 12.49% | 6.2分 |
| 2 | 力诺药包 | 47.41% | 0.24% | 4.6分 |
| 3 | 康众医疗 | 25.09% | 2.04% | 4.8分 |
| 4 | 济民健康 | 16.98% | 3.23% | 4.9分 |
| 5 | 宝莱特 | 15.36% | 14.97% | 5.7分 |
| 6 | 九安医疗 | 14.25% | -18.76% | 4.6分 |
| 8 | ST凯利 | 13.60% | 0.15% | 5.6分 |
| 10 | 英诺特 | 11.15% | 20.43% | 5.9分 |
| 12 | 微电生理 | 9.43% | 2.05% | 4.7分 |
| 14 | 奥美医疗 | 9.30% | -2.95% | 5.1分 |
| 16 | 福瑞医科 | 8.64% | -0.70% | 5.3分 |
| 18 | 天益医疗 | 7.18% | 9.03% | 5.9分 |
| 20 | 春立医疗 | 6.31% | 0.29% | 5.5分 |
| 22 | 可孚医疗 | 5.45% | 1.86% | 6.4分 |
| 24 | 国发股份 | 4.26% | -1.20% | 4.6分 |
| 26 | 之江生物 | 3.95% | -3.25% | 3.9分 |
| 28 | 博拓生物 | 2.89% | 1.99% | 5.0分 |
| 30 | 山外山 | 2.61% | -3.55% | 6.0分 |
| 32 | 艾德生物 | 2.27% | -2.13% | 4.9分 |
| 34 | 东星医疗 | 2.18% | 0.04% | 4.4分 |
| 36 | - | 2.04% | 3.07% | 分 |
| 38 | 大博医疗 | 1.32% | 1.02% | 5.0分 |
| 40 | - | 1.16% | 3.67% | 分 |
| 42 | 正川股份 | 0.97% | -1.29% | 4.2分 |
| 44 | 拱东医疗 | 0.51% | -1.39% | 4.9分 |
| 46 | 安旭生物 | 0.08% | -0.49% | 4.6分 |
| 48 | 翔宇医疗 | -0.23% | 2.09% | 5.2分 |
| 50 | 美好医疗 | -0.34% | 0.42% | 5.8分 |
| 52 | 奕瑞科技 | -0.71% | 5.79% | 6.4分 |
| 54 | 安图生物 | -0.87% | -1.10% | 5.2分 |
| 56 | 瑞迈特 | -1.07% | -0.33% | 5.4分 |
| 58 | 正海生物 | -1.16% | -0.56% | 4.7分 |
| 60 | 东方生物 | -1.48% | -1.57% | 4.8分 |
| 62 | 康德莱 | -1.67% | 0.23% | 5.5分 |
| 64 | 安杰思 | -1.90% | 0.41% | 5.1分 |
| 66 | 麦克奥迪 | -1.95% | 2.58% | 5.0分 |
| 68 | 亚辉龙 | -2.31% | -2.96% | 3.7分 |
| 70 | 联影医疗 | -2.38% | -0.89% | 4.9分 |
| 72 | 黄山胶囊 | -2.45% | -1.36% | 5.9分 |
| 74 | 科美诊断 | -2.70% | -1.63% | 4.2分 |
| 76 | - | -2.76% | 3.84% | 分 |
| 78 | 爱威科技 | -2.95% | 0.30% | 6.0分 |
| 80 | 祥生医疗 | -3.30% | -0.50% | 4.9分 |
| 82 | 山东药玻 | -3.43% | 0.43% | 5.0分 |
| 84 | 美康生物 | -4.07% | 0.61% | 4.5分 |
| 86 | 健尔康 | -4.48% | -0.46% | 4.5分 |
| 88 | 睿昂基因 | -4.54% | -1.70% | 4.5分 |
| 90 | 三诺生物 | -4.59% | -2.29% | 5.3分 |
| 92 | 三鑫医疗 | -4.89% | -5.94% | 4.8分 |
| 94 | 硕世生物 | -5.22% | 9.89% | 4.3分 |
| 96 | 乐普医疗 | -5.49% | -0.61% | 5.1分 |
| 98 | 迈克生物 | -5.59% | -2.11% | 4.3分 |
| 100 | 采纳股份 | -5.76% | 4.39% | 5.1分 |
| 102 | 蓝帆医疗 | -5.83% | -4.38% | 4.5分 |
| 104 | 奥泰生物 | -6.28% | -0.73% | 4.7分 |
| 106 | 迈普医学 | -6.33% | -1.69% | 5.8分 |
| 108 | 爱博医疗 | -6.41% | -2.65% | 4.7分 |
| 110 | 康为世纪 | -7.06% | -0.10% | 4.4分 |
| 112 | 基蛋生物 | -7.25% | -7.16% | 4.7分 |
| 114 | 康泰医学 | -7.49% | -2.02% | 4.3分 |
| 116 | 欧普康视 | -7.84% | -1.62% | 4.8分 |
| 118 | 尚荣医疗 | -8.11% | -3.13% | 5.1分 |
| 120 | 超研股份 | -8.21% | -3.17% | 5.6分 |
| 122 | - | -8.34% | 2.17% | 分 |
| 124 | 迈瑞医疗 | -8.79% | -0.90% | 5.0分 |
| 126 | 新产业 | -9.14% | -2.05% | 5.1分 |
| 128 | 澳华内镜 | -9.28% | -1.89% | 4.4分 |
| 130 | 济高发展 | -9.54% | -4.55% | 4.5分 |
| 132 | - | -9.74% | 2.59% | 分 |
| 134 | 万孚生物 | -11.50% | -1.00% | 3.8分 |
| 136 | 南卫股份 | -12.33% | -1.99% | 5.1分 |
| 138 | 华兰股份 | -15.23% | -13.42% | 5.0分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 76/242 ， 56/242。
[{"date":"2025-09-30","value":"2.42","vol":"2.98"},{"date":"2025-06-30","value":"3.41","vol":"2.34"},{"date":"2025-03-31","value":"3.35","vol":"1.16"},{"date":"2024-12-31","value":"11.15","vol":"0.56"},{"date":"2024-09-30","value":"8.73","vol":"4.62"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.42 | 3.41 | 3.35 | 11.15 | 8.73 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"60.30","vol":"51.74"},{"date":"2025-06-30","value":"62.87","vol":"52.05"},{"date":"2025-03-31","value":"66.67","vol":"51.42"},{"date":"2024-12-31","value":"64.15","vol":"52.52"},{"date":"2024-09-30","value":"63.43","vol":"53.21"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
60.30 | 62.87 | 66.67 | 64.15 | 63.43 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.21 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 117/242 ， 101/242。
[{"date":"2025-09-30","value":"-22.52","vol":"0.26"},{"date":"2025-06-30","value":"-20.92","vol":"-1.09"},{"date":"2025-03-31","value":"-7.06","vol":"-0.12"},{"date":"2024-12-31","value":"10.85","vol":"1.15"},{"date":"2024-09-30","value":"8.83","vol":"0.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-22.52 | -20.92 | -7.06 | 10.85 | 8.83 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.67 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-69.32","vol":"-15.37"},{"date":"2025-06-30","value":"-46.82","vol":"-18.14"},{"date":"2025-03-31","value":"-13.37","vol":"-2.59"},{"date":"2024-12-31","value":"15.18","vol":"-23.09"},{"date":"2024-09-30","value":"9.04","vol":"-20.18"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-69.32 | -46.82 | -13.37 | 15.18 | 9.04 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -20.18 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 62/242 ， 41/242。
[{"date":"2025-09-30","value":"0.24","vol":"0.25"},{"date":"2025-06-30","value":"0.18","vol":"0.17"},{"date":"2025-03-31","value":"0.11","vol":"0.08"},{"date":"2024-12-31","value":"0.47","vol":"0.36"},{"date":"2024-09-30","value":"0.35","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.24 | 0.18 | 0.11 | 0.47 | 0.35 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.90","vol":"1.66"},{"date":"2025-06-30","value":"1.31","vol":"1.12"},{"date":"2025-03-31","value":"0.79","vol":"0.55"},{"date":"2024-12-31","value":"3.09","vol":"2.32"},{"date":"2024-09-30","value":"2.15","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.90 | 1.31 | 0.79 | 3.09 | 2.15 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"24.53","vol":"14.74"},{"date":"2025-06-30","value":"20.76","vol":"15.17"},{"date":"2025-03-31","value":"-18.59","vol":"4.22"},{"date":"2024-12-31","value":"21.32","vol":"29.38"},{"date":"2024-09-30","value":"-4.46","vol":"15.51"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 24.53 | 20.76 | -18.59 | 21.32 | -4.46 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 15.51 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.91","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.15","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.91 | - | 1.15 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 100/242 ， 104/242。
[{"date":"2025-09-30","value":"7.78","vol":"5.66"},{"date":"2025-06-30","value":"5.72","vol":"5.47"},{"date":"2025-03-31","value":"5.78","vol":"5.84"},{"date":"2024-12-31","value":"4.61","vol":"5.30"},{"date":"2024-09-30","value":"7.44","vol":"5.81"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
7.78 | 5.72 | 5.78 | 4.61 | 7.44 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.81 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"6.59","vol":"4.51"},{"date":"2025-06-30","value":"4.91","vol":"4.35"},{"date":"2025-03-31","value":"5.12","vol":"4.73"},{"date":"2024-12-31","value":"4.03","vol":"4.27"},{"date":"2024-09-30","value":"6.09","vol":"4.68"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
6.59 | 4.91 | 5.12 | 4.03 | 6.09 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.68 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 74/242 ， 76/242。
[{"date":"2025-09-30","value":"16.42","vol":"22.07"},{"date":"2025-06-30","value":"18.44","vol":"22.01"},{"date":"2025-03-31","value":"18.69","vol":"21.19"},{"date":"2024-12-31","value":"21.03","vol":"21.94"},{"date":"2024-09-30","value":"17.53","vol":"20.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
16.42 | 18.44 | 18.69 | 21.03 | 17.53 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.67 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.20","vol":"0.71"},{"date":"2025-06-30","value":"0.23","vol":"0.58"},{"date":"2025-03-31","value":"0.23","vol":"0.56"},{"date":"2024-12-31","value":"0.27","vol":"0.55"},{"date":"2024-09-30","value":"0.22","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.20 | 0.23 | 0.23 | 0.27 | 0.22 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"6.34","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"11.97","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.88","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.62","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.46","blueLineValue":"0.31","type":"YC"}]